AUMERIQ Trademark

Trademark Overview

On Friday, February 4, 2022, a trademark application was filed for AUMERIQ with the United States Patent and Trademark Office. The USPTO has given the AUMERIQ trademark a serial number of 97253151. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 25, 2024. This trademark is owned by EQRx International, Inc.. The AUMERIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological, autoimmune, and inflammatory diseases and disorders
aumeriq

General Information

Serial Number97253151
Word MarkAUMERIQ
Filing DateFriday, February 4, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncological, autoimmune, and inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEQRx International, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameEQRx International, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139

Trademark Events

Event DateEvent Description
Monday, March 25, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 25, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 22, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 18, 2022NON-FINAL ACTION E-MAILED
Friday, November 18, 2022NON-FINAL ACTION WRITTEN
Thursday, November 17, 2022ASSIGNED TO EXAMINER
Thursday, July 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 8, 2022NEW APPLICATION ENTERED

Related Keywords

aumeriq inflammatory diseases disorders autoimmune oncological preparations treatment pharmaceutical